Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 9, 2015-01 ,pp. : 1080-1091

Bentham Science Publishers

Access to resources Recommend Favorite

Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 4, 2017-04 ,pp. : 552-565

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 10, 2017-10 ,pp. : 1411-1425

Bentham Science Publishers

Access to resources Recommend Favorite

Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 4, 2009-05 ,pp. : 397-414

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibition: A Novel Approach to Anticancer Therapy

By Paul G. Richardson   Teru Hideshima   Kenneth C. Anderson  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite